[REGN] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
13-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -31.49%
YoY- -79.42%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 725,788 665,700 625,740 610,412 597,027 457,642 439,664 39.63%
PBT 176,078 203,119 175,263 198,153 225,684 147,692 141,831 15.49%
Tax 96,358 110,384 109,820 101,347 84,378 60,316 42,957 71.27%
NP 79,720 92,735 65,443 96,806 141,306 87,376 98,874 -13.36%
Tax Rate -54.72% -54.34% -62.66% -51.15% -37.39% -40.84% -30.29% -
Total Cost 646,068 572,965 560,297 513,606 455,721 370,266 340,790 53.11%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 10.98 13.93 10.46 15.86 23.67 19.09 22.49 -37.97%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS 0.83 0.96 0.69 0.98 1.44 0.89 1.02 -12.82%
EPS Diluted 0.73 0.85 0.61 0.73 1.25 0.79 0.90 -13.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.